Zobrazeno 1 - 10 of 1 924 pro vyhledávání: '"Viñals, F."'
1
Editorial & Opinion
Posterior complex: clue for suspicion of partial agenesis of corpus callosum at fetal brain screening.
Autor: Viñals F; Ultrasound Department, Sanatorio Aleman Clinic, Concepción, Chile.; Obstetrics Department, Medicine Faculty, University of Concepción, Concepción, Chile., Correa F; Fetal and Neonatal Ultrasonography Department, Hospital Lusiadas, Lisbon, Portugal.
Publikováno v: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology [Ultrasound Obstet Gynecol] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.
Zobrazit plný text záznamu
3
Akademický článek
Translational medicine in hereditary hemorrhagic telangiectasia
Autor: Riera-Mestre, A., Cerdà, P., Iriarte, A., Graupera, M., Viñals, F.
Publikováno v: In European Journal of Internal Medicine January 2022 95:32-37
Zobrazit plný text záznamu
5
Akademický článek
Feasibility of extended ultrasound examination of the fetal brain between 24 and 37 weeks' gestation in low-risk pregnancies.
Autor: Viñals F; Sanatorio Aleman Clinic and Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Concepcion, Concepcion, Chile., Correa F; Fetal and Neonatal Ultrasonography Department, Hospital Lusíadas, Lisbon, Portugal., Escribano D; Fetal Medicine Unit-Maternal and Child Health and Development Network, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, 12 de Octubre Research Institute (imas12), Faculty of Medicine, Complutense University of Madrid, Madrid, Spain., Hormazábal L; Sanatorio Aleman Clinic and Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Concepcion, Concepcion, Chile., Diaz L; Sanatorio Aleman Clinic and Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Concepcion, Concepcion, Chile., Galindo A; Fetal Medicine Unit-Maternal and Child Health and Development Network, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, 12 de Octubre Research Institute (imas12), Faculty of Medicine, Complutense University of Madrid, Madrid, Spain., Zambrano B; Sanatorio Aleman Clinic and Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Concepcion, Concepcion, Chile., Quiroz G; Sanatorio Aleman Clinic and Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Concepcion, Concepcion, Chile., Saint-Jean C; Sanatorio Aleman Clinic and Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Concepcion, Concepcion, Chile.
Publikováno v: Journal of perinatal medicine [J Perinat Med] 2023 Apr 18; Vol. 51 (6), pp. 815-822. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma.
Autor: Lorenzo-Sanz L; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain. llorenzo@idibell.cat., Lopez-Cerda M; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain., da Silva-Diz V; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain.; Rutgers Cancer Institute of New Jersey, Rutgers University, 08901, New Brunswick, NJ, USA., Artés MH; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Llop S; Medical Oncology Department, Catalan Institute of Oncology (ICO), 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Penin RM; Pathology Service, Bellvitge University Hospital/IDIBELL, 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Bermejo JO; Plastic Surgery Unit, Bellvitge University Hospital/IDIBELL, 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Gonzalez-Suarez E; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain., Esteller M; Josep Carreras Leukaemia Research Institute (IJC), 08916, Badalona, Barcelona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, 28029, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), 08908, Barcelona, Spain., Viñals F; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), 08908, Barcelona, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO)/IDIBELL, 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Espinosa E; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, 28029, Madrid, Spain.; Medical Oncology Department, La Paz University Hospital, Autonomous University of Madrid (UAM), 28046, Madrid, Spain., Oliva M; Medical Oncology Department, Catalan Institute of Oncology (ICO), 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Piulats JM; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain.; Medical Oncology Department, Catalan Institute of Oncology (ICO), 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Martin-Liberal J; Medical Oncology Department, Catalan Institute of Oncology (ICO), 08908, L'Hospitalet de Llobregat, Barcelona, Spain., Muñoz P; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain. p.munoz@idibell.cat.
Publikováno v: Nature communications [Nat Commun] 2024 Jun 24; Vol. 15 (1), pp. 5352. Date of Electronic Publication: 2024 Jun 24.
Zobrazit plný text záznamu
7
Akademický článek
Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.
Autor: Gendrau-Sanclemente N; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Figueras A; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Gracova K; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Lahiguera Á; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Alsina-Sanchís E; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Marín-Jiménez JA; Cancer Immunotherapy (CIT) Group-ProCURE, Bellvitge Biomedical Research Institute (IDIBELL) - OncoBell, Barcelona, Spain.; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Barcelona, Spain., Vidal A; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Department of Pathology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Matias-Guiu X; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Department of Pathology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Fernandez-Gonzalez S; Department of Gynaecology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain., Barahona M; Department of Gynaecology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain., Martí L; Department of Gynaecology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain., Ponce J; Department of Gynaecology, University Hospital of Bellvitge (IDIBELL), Barcelona, Spain., Viñals F; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Departament de Ciències Fisiològiques, Universitat de Barcelona, Spain.
Publikováno v: Molecular oncology [Mol Oncol] 2024 Jan; Vol. 18 (1), pp. 136-155. Date of Electronic Publication: 2023 Dec 01.
Zobrazit plný text záznamu
8
Akademický článek
New genetic drivers in hemorrhagic hereditary telangiectasia.
Autor: Cerdà P; HHT Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Castillo SD; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Aguilera C; HHT Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Genetics Laboratory, Laboratori Clínic Territorial Metropolitana Sud, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Iriarte A; HHT Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Rocamora JL; HHT Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Molecular Signaling Group, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Larrinaga AM; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Viñals F; Molecular Signaling Group, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Physiological Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona (UB), L'Hospitalet de Llobregat, Spain; Program Against Cancer Therapeutic Resistance (ProCURE), Institut Catala d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain., Graupera M; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Riera-Mestre A; HHT Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona (UB), L'Hospitalet de Llobregat, Spain. Electronic address: ariera@bellvitgehospital.cat.
Publikováno v: European journal of internal medicine [Eur J Intern Med] 2024 Jan; Vol. 119, pp. 99-108. Date of Electronic Publication: 2023 Sep 09.
Zobrazit plný text záznamu
9
Akademický článek
Feasibility and agreement of including anterior-posterior complexes and landmarks of the proximal hemisphere into basic examination of the fetal brain: A prospective study.
Autor: Hormazabal L; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile., Correa F; Fetal and Neonatal Ultrasonography, Department, Hospital Lusíadas, Lisbon, Portugal., Escribano D; Fetal Medicine Unit-Maternal and Child Health and Development Network, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, 12 de Octubre Research Institute (imas12), Complutense University of Madrid, Madrid, Spain., Quiroz G; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile., Saint-Jean C; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile., Espinel A; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile., Diaz L; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile., Zambrano B; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile., Galindo A; Fetal Medicine Unit-Maternal and Child Health and Development Network, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, 12 de Octubre Research Institute (imas12), Complutense University of Madrid, Madrid, Spain., Viñals F; Centro AGB Ultrasonografía, Clínica Sanatorio Alemán, Facultad de Medicina, Universidad de Concepción, Concepción, Chile.
Publikováno v: Prenatal diagnosis [Prenat Diagn] 2020 Apr; Vol. 40 (5), pp. 596-604. Date of Electronic Publication: 2020 Mar 02.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje